Knockdown of RET was first established in mouse N2A neuroblastoma cells using a panel of shRNAs, from which we selected the two most effective to prepare lentiviral vectors in Lenti-HEK293 cells (Supplementary Fig. 2A, B). The gene discussed is RET; the disease is neuroblastoma.